Genetic control of mRNA splicing as a potential mechanism for incomplete penetrance of rare coding variants.

TitleGenetic control of mRNA splicing as a potential mechanism for incomplete penetrance of rare coding variants.
Publication TypeJournal Article
Year of Publication2023
AuthorsEinson, J, Glinos, D, Boerwinkle, E, Castaldi, P, Darbar, D, de Andrade, M, Ellinor, P, Fornage, M, Gabriel, S, Germer, S, Gibbs, RA, Hersh, CP, Johnsen, J, Kaplan, R, Konkle, BA, Kooperberg, C, Nassir, R, Loos, RJF, Meyers, DA, Mitchell, BD, Psaty, B, Vasan, RS, Rich, SS, Rienstra, M, Rotter, JI, Saferali, A, M Shoemaker, B, Silverman, E, Smith, AVernon, Mohammadi, P, Castel, SE, Iossifov, I, Lappalainen, T
Corporate AuthorsNHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
JournalbioRxiv
Date Published2023 Jan 31
Abstract

Exonic variants present some of the strongest links between genotype and phenotype. However, these variants can have significant inter-individual pathogenicity differences, known as variable penetrance. In this study, we propose a model where genetically controlled mRNA splicing modulates the pathogenicity of exonic variants. By first cataloging exonic inclusion from RNA-seq data in GTEx v8, we find that pathogenic alleles are depleted on highly included exons. Using a large-scale phased WGS data from the TOPMed consortium, we observe that this effect may be driven by common splice-regulatory genetic variants, and that natural selection acts on haplotype configurations that reduce the transcript inclusion of putatively pathogenic variants, especially when limiting to haploinsufficient genes. Finally, we test if this effect may be relevant for autism risk using families from the Simons Simplex Collection, but find that splicing of pathogenic alleles has a penetrance reducing effect here as well. Overall, our results indicate that common splice-regulatory variants may play a role in reducing the damaging effects of rare exonic variants.

DOI10.1101/2023.01.31.526505
Alternate JournalbioRxiv
PubMed ID36778406
PubMed Central IDPMC9915611
Grant ListR01 GM140287 / GM / NIGMS NIH HHS / United States
R01 HL120393 / HL / NHLBI NIH HHS / United States
UM1 HG008895 / HG / NHGRI NIH HHS / United States
R01 HL092577 / HL / NHLBI NIH HHS / United States
U01 HL120393 / HL / NHLBI NIH HHS / United States
R01 MH106842 / MH / NIMH NIH HHS / United States
UM1 HG008901 / HG / NHGRI NIH HHS / United States
HHSN268201500014C / HL / NHLBI NIH HHS / United States
R01 GM122924 / GM / NIGMS NIH HHS / United States
UM1 HG008898 / HG / NHGRI NIH HHS / United States
R01 HL117626 / HL / NHLBI NIH HHS / United States
U54 HG003067 / HG / NHGRI NIH HHS / United States
R01 HL121007 / HL / NHLBI NIH HHS / United States
R01 HL089856 / HL / NHLBI NIH HHS / United States
U54 HG003273 / HG / NHGRI NIH HHS / United States
HHSN268201800001C / HL / NHLBI NIH HHS / United States
UM1 HG008853 / HG / NHGRI NIH HHS / United States
HHSN268201500015C / HL / NHLBI NIH HHS / United States
HHSN268201500016C / HL / NHLBI NIH HHS / United States
HHSN268201600033C / ES / NIEHS NIH HHS / United States